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Snyder, Erika A., Evaluating sources of omega-3 fatty acids for their benefits on late 
gestation mares and neonatal foals. Master of Science in Agriculture, December, 2020, 
Sam Houston State University, Huntsville, Texas. 
Maternal supplementation of omega-3 fatty acids during late gestation has been 
shown to have a variety of benefits on the dam and resulting offspring. However, 
research in mares and foals is limited. The current study utilized 13 American Quarter 
Horse mares and their foals, assigned to one of three dietary treatments: a control basal 
diet (CON, n=5), a basal diet with the addition of a marine algae supplement (ALG, n=5) 
or a basal diet with the addition of a flaxseed supplement (FLAX, n=3). Mares were 
placed on treatments 30 days before their expected foaling date and continued through 
day 5 post- parturition. Samples of plasma were collected from mares prior to beginning 
supplementation, day 0 post-parturition, day 5 and day 30 post-parturition. Milk samples 
were collected from mares at day 0, 5 and 30 post-parturition. Plasma samples were 
collected from foals at birth, day 5 and day 30 post-parturition. Fatty acid compositions 
of mare plasma, mare milk and foal plasma were determined. Data was analyzed using 
the MIXED procedure of SAS. Foals born to supplemented mares exhibited increased 
plasma DHA levels at birth and foals born to ALG mares had greater plasma EPA levels. 
Samples obtained from foals at birth prior to nursing had the highest DHA content 
compared to all other samples. No differences were observed in mare plasma or milk. 
The results of the foal plasma suggest the most efficient avenue for increasing foal DHA 
levels is through maternal supplementation of omega-3 fatty acids in late gestation and 
that supplementation for the final 30 days of gestation is sufficient to see changes.  
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Essential fatty acids (EFA) are a specific type of polyunsaturated fatty acid 
(PUFA) composed of a long hydrocarbon chain that contains a double bond between the 
3rd and 4th (omega-3) or 6th and 7th (omega 6) carbons from the methyl end. Animals are 
unable to produce double bonds in these locations, and therefore must consume fats that 
contain them. This study specifically investigates the omega 3 fatty acids, 
docosahexaenoic acid (DHA, C22:6n3), eicosapentaenoic acid (EPA, C20:5), and alpha-
linolenic acid (ALA, C18:3n3). These PUFA are found in all body tissues but are most 
abundant in the cellular membranes of nervous, reproductive, and retinal tissues 
(Arterburn et al., 2006). In cell membranes, DHA incorporates into cell membranes 
where it promotes more efficient nerve cell signal transmission and resistance to 
mechanical stress and cellular injury (Stillwell and Wassall, 2003). Docosahexaenoic acid 
is also used to produce anti-inflammatory compounds of the prostaglandin cascade, and 
might therefore influence the body’s repair response to infection and injury (Ricciotti and 
Fitzgerald, 2011).  
Horses obtain EFA through their native diet as well as from supplemental fat 
sources. Essential fatty acids can be obtained from forages such as grass hay and pasture, 
with grasses being abundant in ALA but having nearly undetectable EPA and DHA 
levels. Additional sources of ALA include seed oils such as those from flaxseed, soybean, 
and chia seeds, which are comprised of 55%, 8% and 64% ALA, respectively. The 
predominant omega 3 fatty acid consumed by horses is ALA, which can be elongated to 





ALA, the efficiency of this process is unknown in horses. Some research has investigated 
efficiency in other species, such as tree swallows which were found to have conversion 
rates of 3 and 11 percent in the muscle and liver, respectively (Twining et. al, 2018). In 
humans, conversion rates are estimated between 0.5 and 9 percent when measured in total 
plasma lipids (Burdge, 2004). Therefore, increasing dietary ALA may not increase the 
amount of DHA available to nerve cells and the immune system. Direct supplementation 
of DHA and EPA to horses in the form of fish and microalgae oils may be a more 
effective way to promote the nerve cell and anti-inflammatory benefits of DHA. 
This project investigated DHA, EPA and ALA plasma levels in foals prior to and 
after consumption of milk from mares supplemented with EFA sources for the last 30 
days of gestation. The objective of this project included investigating if foals were 
obtaining these EFAs through placental transfer during late gestation or through maternal 







The objective of this study is to test the hypothesis that foals born to mares supplemented 
with marine-derived algae during late gestation will have greater plasma DHA 
concentrations, a shorter time to stand and suckle after birth, and stronger immune 
responses to colostrum ingestion than foals born to either control mares or mares 








Chemistry of Fats 
Dietary fats and oils consist of triglycerides, organic compounds consisting of 
three fatty acids (FA) bound to a glycerol structure. Triglycerides can appear as either 
liquid or solid at room temperature depending on the saturation status of their fatty acids.  
The FA chemical structure is composed of a chain of at least 2 carbon (C) atoms, with a 
methyl group at the tail (omega end) and a carboxyl group at the head (delta end), which 
is attached to a glycerol when in triglyceride structure. Fatty acids are then divided into 
saturated or unsaturated categories. Saturated fatty acids lack double bonds between C 
atoms and are most often found in dairy products and animal fats (Valenzuela and 
Morgado, 1999). This lack of double bonds induces a straight and unbending structure 
that contributes to solidification at room temperature. Unsaturated fatty acids have at 
least one double bond between C atoms and are most often found in vegetable oils 
(Sardesai, 1992). The double bonds impart strength allowing for bending of the structure, 
changing its shape and contribute to the triglyceride being liquid at room temperature. 
Unsaturated FA can be further divided based on their number of double bonds. 
Monounsaturated fatty acids have only one double bond while PUFA have two or more 
double bonds. Fatty acids can also be classified by their carbon chain length, as either 
short (2-4 C), medium (6-10 C), long (12-18 C), or very long (20 or more C).  
Essential Fatty Acid Chemistry 
Essential fatty acids are a specific type of PUFA with at least one double bond 





bonds is achieved by desaturase enzymes, each of which desaturate a specific C position. 
Animals are unable to produce the double bonds in EFA because they lack the desaturase 
enzymes for the omega 3 and 6 positions (Voet and Voet, 2004). Therefore, these PUFA 
are essential for inclusion in the diet. Animals are able to consume ALA and elongate the 
delta end in order to produce DHA, however, the conversion rates vary with species and 
are still largely unknown (Plourde and Cunnane, 2007). There are two families of EFA, 
omega 3 and omega 6. 
Omega 6 Fatty Acids (LA & AA) structures 
Omega 6 EFA are named as such due to the double bond in their structure located 
at the 6th C atom from the omega tail. This class of fatty acids includes linoleic acid (LA; 
C18:2n-6) and arachidonic acid (AA; C20:4n-6). Animals are capable of metabolizing 
LA into AA through chain lengthening, with AA being the active form. 
Omega 3 Fatty Acids (ALA, EPA & DHA) structures 
Omega 3 EFA are also named for the location of their double bond, with the first 
double bond in their structure being at the 3rd C atom from the tail. This class of PUFA 
includes ALA (C18:3n-3), EPA (C20:5n-3), and DHA (C22:6n-3). Animals are capable 
of metabolizing ALA into EPA and DHA through chain lengthening.  
Biological Functions of Essential Fatty Acids 
Docosahexaenoic acid is found all throughout the body, but most importantly in 
the cellular membranes of nervous, reproductive and retinal tissues (Arterburn et al., 
2006). Docosahexaenoic acid is the most abundant omega-3 fatty acid in the brain and 





(Davis-Bruno and Tassinari, 2011). Five percent of the weight of a neuron's plasma 
membrane is composed of DHA. Docosahexaenoic acid interacts within cell membranes, 
incorporating into the membrane phospholipids to alter shape, fluidity, elasticity, and 
permeability to increase the efficiency of nerve cell communication (Stillwell and 
Wassall, 2003). 
Nerve Cell Transmission 
Docosahexaenoic acid has been shown to improve cognition by improving nerve 
cell transmission. One specific function is modulating the carrier-mediated transport of 
choline, glycine, and taurine, which are precursors to the neurotransmitters that help to 
produce cognitive and motor functions (Nelson and Cox, 2005). Docosahexaenoic acid is 
essential for the growth and functional development of the brain in infants and is required 
for the maintenance of normal brain function in adults. The inclusion of plentiful DHA in 
the diet improves learning ability, whereas deficiencies of DHA are associated with 
deficits in learning (Horrocks and Yeo, 1999). Phosphatidylserine (PS) is a phospholipid 
component of the cell membrane that controls apoptosis, and low DHA levels in the 
neuronal membranes lower neural cell PS concentrations, therefore increasing neural cell 
death (Kim, Akbar and Kim, 2001). DHA levels are found to be reduced in the brain 
tissue of severely depressed patients leading researchers to believe that due to their anti-
inflammatory properties, EPA and DHA can be used in the treatment of depression 
(Horrocks and Yeo, 1999). 
Extensive research in humans has suggested that DHA and EPA supplementation 
can aid in the prevention of heart disease, cancer, diabetes and autoimmune disorders. 





vascular compliance and red blood cell deformability, benefits due to plasma membrane 
fluidity, as well as enhancing insulin sensitivity, which may be more closely related to the 
anti-inflammatory actions of DHA. DHA has been accepted as necessary in 
developmental diets for visual and cognitive development in humans and further benefits 
continue to be researched. 
Inflammation: Eicosanoids and Docosanoids 
The EFA, EPA and DHA, are also precursors of eicosanoids and docosanoids, 
compounds that act as signaling molecules for various immunological processes. 
Eicosanoids that are derived from omega 6 EFA such as prostaglandins and 
thromboxanes are an integral part of inflammatory and immune responses as well as 
smooth muscle contractions (Ricciotti and Fitzgerald, 2011). Alternatively, eicosanoids 
derived from omega 3 EFA such as resolvins and protectins are signaling molecules that 
are involved in promoting normal cell function after inflammation from tissue injuries by 
orchestrating the timely resolution of the inflammation (Kohli and Levy, 2009).  
Eicosanoids that are produced from the metabolism of AA occur through two 
distinct pathways. The cyclooxygenase (COX) pathway produces prostaglandins (PG) 
and thromboxanes (TX) while the lipoxygenase (LOX) pathway produces leukotrienes 
(LT) and hydroperoxytetraenoic acid and hydroxyeicosatetraenoic acid. Leukotrienes are 
inflammatory mediators that regulate immune response by triggering contractions in the 
smooth muscle (Salmon and Higgs, 1987). Specific metabolites and their functions 
include prostaglandin F2 alpha (PGF2a) that induces uterine and smooth muscle 
contractions and thromboxane A2 (TXA2), which is a potent vasoconstrictor and induces 





Eicosanoids that are produced from the metabolism of EPA occur through the 
same COX and LOX pathways, however, have different potency and function. 
Eicosapentaenoic acid that is metabolized through the COX pathway produces a different 
type of PG and TX, and similarly, EPA metabolized through the LOX pathway produces 
a different series of LT. An important eicosanoid derived from EPA is prostaglandin E3 
(PGE3) which has vasodilator and anti-inflammatory activities. Arachidonic acid and 
EPA compete for enzyme availability in the COX and LOX pathways, therefore, dietary 
intake and supply can regulate the types of eicosanoids being produced and ultimately the 
inflammation/anti-inflammation balance (King et al., 2008).  
Essential Fats in the Equine Diet 
Horses originated as purely grazers, with their diet made up entirely of fresh 
grasses found in their habitats. This type of diet allows the horse to consume an 
approximate 3:1 ratio of omega 3:6 FA. When horses became domesticated and humans 
began to feed them grains to increase energy, their diet significantly changed, and the FA 
ratio with it. The current approximate ratio is inverted to 1:10. This ratio can be restored 
through the supplementation of FA to the equine diet.  
Ingredient Contribution of Fat into Diet 
Horses obtain their required energy through their diet. This can be in the form of 
carbohydrates, protein, or fats. While carbohydrates are often used more in the diets, fats 
produce 2.25 the amount of energy as carbohydrates or protein. The energy requirement 
of the horse depends on its current stage of life. Factors such as age, size, workload, 
location and pregnancy status play a large role in determining the energy requirement. 





to provide the horse with essential fatty acids. The National Research Council (NRC) has 
developed recommended nutrient requirement levels depending on the status of the horse.  
Digestion of Fats 
Digestion and metabolism of fat in the horse involves a complex series of 
biological processes that involve a variety of body systems. While human fat digestion 
begins in the mouth with lingual lipase, equine saliva has limited enzymatic activity and 
only serves to lubricate food. In equines, true fat digestion begins in the stomach where 
FA are hydrolyzed from triglycerides by gastric lipase. The majority of the digestion 
occurs in the small intestine, where bile secreted by the liver into the duodenum acts to 
emulsify the fat present. Utilizing pancreatic lipase, the hydrolysis of FA from the 
triglyceride produces two free FA and one 2-monoacyl-sn-glycerol. Short and medium 
chain free FA are absorbed by passive diffusion into the enterocyte where they enter the 
portal vein and travel to the liver. Long chain free FA must combine with 
lysophospholipids and bile salts in the lumen to create micelles. The micelles are then 
absorbed by the enterocytes by FA transporters. Within the enterocyte, triglycerides are 
reformed and combined with cholesterol esters and apolipoprotein B to form 
chylomicrons. Chylomicrons allow the hydrophobic fats to travel into the lymphatic 
system where they enter the vena cava via the thoracic duct. Once in the blood, 
chylomicrons react with lipoprotein lipase to release the FA for uptake by tissues and 
adipocytes.  
De novo synthesis of FA in the equine is accomplished by the liver, however not 
all FA can be synthesized. While mammals are able to insert the double bond at the 9th 





to insert double bonds further (Wathes et al., 2007). This prevents the synthesis of 
linoleic acid (LA; C18:2n-2) and alpha-linolenic acid (ALA; C18:3n-3) in mammals, 
making them essential FA that must be provided in the diet. Once consumed, animals can 
convert LA and ALA to longer chain PUFA through series of elongation and desaturation 
steps. The LA can become arachidonic acid (ARA; C20:4n-6) and ALA can produce 
eicosapentaenoic acid (EPA; C20:5n-3) and docosahexaenoic acid (DHA; C22:6n-3). 
Unlike mammals, plants have the necessary desaturase enzymes capable of 
inserting double bonds into the 12th and 15th carbon positions to create omega-3 and 
omega-6 FA. Microorganisms are able to desaturate at the 6th carbon of ALA to produce 
stearidonic acid, which is then elongated to produce eicosatetraenoic acid. That is then 
desaturated at the 5th carbon to produce EPA which is elongated to produce DPA. DPA is 
then desaturated at the 4th carbon to produce DHA.  
Humans and horses must go through a series of conversions. The resulting EPA is 
twice elongated (24:5n-3 to 24:6n-3) then shortened to DHA (22:6n-3) via beta oxidation 
in a pathway otherwise known as “Sprecher’s Shunt.” (Sprecher and Chen, 1999). In 
humans, research has shown a higher conversion of ALA to DHA in women than in men 
(Burdge and Wootton, 2002), but it is unknown if gender effects occur in horses.  
Sources of Omega Fatty Acids in Equine Diet 
Equine diets provide horses with their essential n-6 FA, LA through cereal grains, 
oilseed meals, forages and oils. These diets are also often supplemented with vegetable 
oils and other fats in order to increase the energy density of the diet. Oils such as 
sunflower, safflower, peanut, soy and corn are high in LA making them popular for 





bahiagrass, also contain LA. LA can be desaturated and elongated to produce dihomo-
gamma-linolenic acid (DGLA) and the previously mentioned ARA which are both 
important precursors to eicosanoids. ARA is also one of the two major PUFA found in 
the neuron-dense grey matter of the brain (Lauritzen and Carlson, 2011). Past research 
has found that supplementation of n-6 FA to the equine diet results in multiple 
physiological responses related to exercise, athletic performance and behavior 
(Woodward et. al, 2007). 
The other essential equine FA, ALA is an n-3 FA. Most of the ALA in the equine 
diet is derived from forages but it is at very low concentrations in regards to percent of 
total fatty acids. ALA is found mainly in seed oils such as flaxseed (linseed, 55%), 
soybeans (8%), and chia seeds which have up to 64% ALA as a percent of oil. ALA 
serves as the precursor for synthesis of the n-3 long chain PUFA, EPA and DHA. 
While DHA can be synthesized from ALA, it can also be obtained directly from 
maternal milk, fish oil, or algae oil. Most of the DHA in fish and multi-cellular organisms 
with access to cold-water oceanic foods originates from photosynthetic and heterotrophic 
microalgae and becomes increasingly concentrated in organisms the further they are up 
the food chain. DHA can also be commercially manufactured from microalgae. In strict 
herbivores, DHA is manufactured internally from α-linolenic acid, a shorter omega-3 
fatty acid. To be effective, DHA and EPA need to be supplemented to the equine diet in 
the form of fish and microalgae oils. 
Elongation and Competition 
In humans, the ALA to DHA conversion rate is thought to be < 1% (Arterburn et 





Past research has shown no impact on the proportion of DHA in the blood when 
supplemented with flaxseed (ALA) (Hess et al., 2012; Vineyard et al., 2010). Therefore, 
it seems that the only way to increase DHA within equine blood circulation is to 
supplement directly with a DHA source such as fish oil or marine algae (Hall et al., 2004; 
King et al., 2008; Vineyard et al., 2010). 
As discussed earlier, LA and ALA can be used as precursors to synthesize various 
long chain PUFA. This extensive conversion process uses the delta-6 and delta-5 
desaturases for both n-6 and n-3 production. The limited availability of these enzymes 
causes competition between LA and ALA for use of the two pathways. The resulting 
ARA, EPA and DHA levels are therefore impacted by this competition. 
Proper n-6 to n-3 Ratio 
Omega-3’s have been shown to reduce inflammation while omega-6’s have been 
shown to promote inflammation, making it vital to improve the ratio of n-3:n-6. 
Inflammation is vital to mediate tissue repair, so omega-6 fatty acids should still be 
incorporated into the diet. Human research has found that the average American citizen’s 
diet reflects a 17:1 n-6 to n-3 ratio (Simopoulos, 2008). However, further research 
suggests that the ideal n-6 to n-3 ratio for humans is around 4:1 (Davis-Bruno and 
Tassinari, 2011). The ideal ratio for equines has yet to be established. 
Equine Reproduction 
The industry and terminology 
Horses are considered “long day breeders,” meaning they will come into estrous as the 





throughout the spring and summer as they are seasonally polyestrous. In the equine 
industry, mares can be bred by live cover or artificial insemination. Live cover involves 
both the mare and stallion being physically present and involves the full process of 
vaginal intercourse. Live cover can be done with human intervention or with no outside 
interference such as pasture breeding. Artificial insemination involves the insertion of 
previously collected stallion semen into the mare’s reproductive tract. Artificial 
insemination allows the broadened use of high quality genetics as well as lowers the risk 
of injury or disease to both the animals and humans involved.  
The normal range for the equine gestation is 335 to 360 days. This results in mares giving 
birth, or foaling, during the late winter to early summer. As mares approach parturition 
their body will begin to alter in preparation. Signs begin up to two weeks before foaling 
and can include accumulating milk in the udder. Approximately 24 hours before foaling 
the muscles around the tail head and vulva will relax and dried milk may accumulate on 
the ends of the teats, otherwise known as waxing. The process of parturition is regarded 
in three stages. Stage one begins when the mare begins to show to be restless, often 
laying down and standing repeatedly. Stage one ends when the amniotic sac protrudes 
from the vulva and breaks, releasing the amniotic fluid. Stage two involves the 
appearance of the foal, starting with one front hoof soon followed by the next, followed 
by the nose showing the foal is in the sternal position, and quickly followed by the 
remainder of the body. Stage three is the expulsion of the afterbirth and placenta within 
one to three hours after emergence of the foal. Retention of the placenta past this time is 
considered a retained placenta and should be treated as an emergency as retention can 





Once the foal has been born, the mare will clean off the amniotic fluids and remaining 
birth sac from the foal. The foal will immediately begin to attempt to stand and a 
successful attempt can take up to an hour but more often is within 15 minutes. Once the 
foal has successfully stood and walked, it will attempt to nurse from the mare. This 
process may take a few hours but it is important for the foal to nurse in the first twelve 
hours of life to receive the colostrum crucial to its immune system. Foals should also pass 
the meconium, or first bowel movement, shortly after successful nursing. IgG levels 
should be checked at twelve hours of life to ensure proper colostrum intake.  
Broodmare management 
Broodmare nutrition is vital to ensuring the success of a breeding program when 
the goal is to produce live, healthy foals. Good body condition is essential to improving 
reproductive efficiency as it can affect conception rates, anovulatory length and number 
of cycles per conception. To improve body condition, fat is often added to the equine 
diet. Cattle producers often add fat to the diet of their herd in order to increase energy 
content and this has shown to also have positive impacts on reproductive health (Gulliver 
et al., 2012).  
Nutritional Assessments 
A Body Condition Score (BCS) assessment can help to determine the nutritional 
status of a horse from an external inspection. The Henneke System (1983) uses a 9-point 
scale, with 1 being poor and 9 being extremely fat. The accepted ideal range is from a 4 
to a 6, depending on the horse’s individual needs. The score is determined by an overall 





Another equine nutritional assessment is the rump fat thickness measurement. A 
point is determined at approximately 5 cm lateral from the midline at the midpoint of the 
pelvic bone and the fat thickness is measured using b-sound ultrasonography. This 
measurement can then be used in an equation to determine the animal’s body fat 
percentage. The equation is as follows (Westervelt et al., 1976): 
% body fat = 8.64 + {4.7 X (rump fat in centimeters)} 
PUFA Supplementation During Gestation 
Gestation Length 
While cattle research has shown the specific FA influence on reproductive 
mechanisms, there is limited research done on the reproductive efficiency of mares when 
supplemented with specific fatty acids.  
Human trials suggest that third trimester diets high in n-3 FA may increase the 
length of gestation (Gulliver et al., 2012). It is hypothesized that the previously described 
competition for delta-6 desaturase and COX pathway enzymes increases series 1 and 3 
PG while decreasing the series 2 PG that produces stronger uterine contractions (Duvaux-
Ponter et al., 2004). Pickard et al. (2008) observed a tendency for longer gestation in 
ewes supplemented with DHA in the form of algae oil when compared to a control diet.  
Capper et al. (2006) also observed that when ewes were supplemented with fish oil, 
gestation increased significantly by 2 d compared to ewes supplemented with palm oil.  
However, no treatment difference was observed in gestation length (Mattos et al., 2004) 
or rate of placental expulsion (Kemp et al., 1998) in dairy cows that were supplemented 





Duvaux-Ponter et al. (2004) reported that the gestation length was not affected by diet 
when pregnant mares were supplemented with either linseed (ALA) or rapeseed (LA) for 
1.5 months prior to their expected foaling date.  
Transfer to the Fetus 
The last trimester of pregnancy in mares requires an increase in energy, protein, 
calcium and phosphorus due to the significant increase in fetal growth. During gestation, 
the placenta provides maternal nutrients to the fetus, gas exchange, hormone secretions, 
and the elimination of fetal wastes through simple or facilitated diffusion and active 
transport.  The mare has a diffuse epitheliochorial placenta with clusters of 
microcotyledons that are formed from numerous chorionic villi connecting the fetal and 
the maternal placental interface (Senger, 1997). In humans, maternal transfer of ALA and 
LA to the fetus is influenced by maternal PUFA intake, functionality of the placenta, and 
ability of DHA mobilization/uptake by fatty acid binding proteins and fatty acid 
transporters in the maternal placenta side (Lauritzen and Carlson, 2011). 
In humans, there is a higher concentration of FA in plasma during the last 
trimester of pregnancy due to a maternal change in lipid metabolism in which fat deposits 
are catabolically broken down (Herrera, 2002).  Triglycerides cannot pass directly 
through the placenta, but LPL and lipoprotein receptors along with facilitated membrane 
translocation within the placenta enable FA to transfer into the placenta and ultimately to 
the fetus (Herrera, 2002).  DHA seems to be accumulated more than any other FA in fetal 
circulation suggesting specificity for DHA transport across the placenta which also 
contributes to the higher amounts of DHA in fetal adipose tissue after birth (Lauritzen 





It is hypothesized that the equine placenta is permeable to FA and that the equine 
placenta and/or the foals are able to synthesize the long chain PUFA from the maternally 
derived essential FA. While it is still uncertain if the placenta or foal possesses the ability 
to convert ALA to DHA, a study showed that umbilical vein plasma had concentrations 
of long-chain PUFA derived from LA and ALA, which were not seen in the maternal 
plasma suggesting placental or fetal conversion (Stammers et al., 1991). How this occurs 
is still unknown.  
Post foaling behavior 
The instinctual behavior of neonates has also been shown to be altered by n-3 
supplementation in other species. In lambs, the latency of time to stand was decreased for 
lambs born to ewes fed algae oil compared to control diets (Pickard et al., 2008). 
Similarly, the latency to suckle in newborn lambs was decreased when ewes were fed a 
fish oil supplemented diet (Capper et al., 2006). While the actual cause behind the 
behavioral change is unknown, when lambs were sacrificed, a lower n-6 to n-3 ratio in 
the brain tissue was noted in supplemented lambs (Capper et al., 2006).  
Rebreeding effectiveness 
N-3 supplementation has also been shown to have positive effects after parturition 
in preparation for the next breeding. Rebreeding of mares and ensuring a successful 
pregnancy on the first attempt is vital to optimizing production and performance. This is 
often done by rebreeding on foal heat, the first follicular cycle usually occurring six to 
eight days after parturition. DHA supplementation has been shown to improve uterine 





Ovarian artery blood flow has also been improved with n-3 supplementation, thus 
increasing blood flow to the dominant follicle before foal heat. Improved vasculartiy of 
follicles prior to ovulation has been shown to improve fertility in mares (Silva et al., 
2006). It is thought that oocyte viability may be linked to follicular size and therefore 
overall fertility (Morel et al., 2010). In cattle supplemented with flaxseed oil (n-3 FA), 
the average diameter of the ovulatory follicle was reported to be significantly larger than 
those cattle supplemented with sunflower seed oil (n-6 FA) (Ambrose et al., 2006). This 
study also showed improvements in pregnancy rates and lowered pregnancy losses in n-3 
supplemented cows. In contrast, Gulliver et al. (2012), found that n-6 FA 
supplementation in cattle resulted in lower pregnancy rates. It is hypothesized that diets 
high in n-6 FA increase the PGF2a concentration and may lower fertility in cattle due to a 
loss of a functioning corpus luteum (Gulliver et al., 2012).  Currently this has not been 
investigated or confirmed in mares. 
N-3 supplementation has been beneficial in improving breeding success in mares 
for both insemination and live cover techniques. For example, omega-3 supplementation 
has been shown to inhibit the production of cytokines, chemicals critical for 
inflammation response. A 2014 study by Brendemuehl et al., using omega-3 supplements 
demonstrated a reduced inflammatory response in mares bred with frozen semen. For live 
cover breedings, omega-3 supplemented mares have been shown to be less likely to have 
uterine fluid (23%) compared to non-supplemented mares (50%) (Brendenmuehl, Kopp 







Passive Immunity Transfer to Foals 
When foals are first born they lack the proper antibodies for full immunity to new 
pathogens. Therefore, foals must receive these antibodies through the mare’s first milk, 
or colostrum. Mare colostrum consists of 3 important immunoglobulins: immunoglobulin 
G (IgG), immunoglobulin M (IgM), and immunoglobulin A (IgA). As the mare 
approaches parturition, colostrum is produced in the mammary tissue with the highest 
concentrations of IgG and IgM available to the foal immediately after birth. The 
concentration and availability of these immunoglobulins rapidly declines each hour 
postpartum. By hour 12 to 18 postpartum, IgG concentrations in mare mammary 
secretions are only 5 to 25% compared to the levels immediately after foaling, and by 8 
to 16 h postpartum are too low to provide any significant immunity (Lewis, 1995). 
Newborn foals must ingest and absorb colostrum immunoglobulins to reduce risk of 
infection as they are without circulating immunoglobulins at birth (Lewis, 1995). 
Immunoglobulins cannot cross the maternal-fetal placenta interface and thus, the foal 
must receive the mare’s immunoglobulin resistance against disease via colostrum until 
the foal develops an immune system of its own. Absorption of the immunoglobulins 
occurs through enterocyte cells that line the lumen of the small intestines (McClure et al., 
2001). IgA is special as it is not absorbed by the small intestines, but instead provides the 
gastrointestinal tract with protection against infection and, as opposed to IgG and IgM, its 
concentration increases postpartum (Lewis, 1995).  
N-3 supplementation has been shown to have beneficial effects on enterocyte 





better fluidity when the plasma membrane is composed more of PUFA than of saturated 
fatty acids (Duvaux-Ponter et al., 2004). This may allow for more immunoglobulins to 
pass into PUFA rich enterocytes within the small intestine of the newborn foal. However, 
no treatment differences were observed in IgG levels measured in foal plasma when 
pregnant mares were supplemented with either an ALA (linseed) or LA (rapeseed) during 
early gestation and lactation (Duvaux-Ponter et al., 2004). While the researchers did not 
directly investigate if DHA concentrations in the dams milk, or foal plasma, were altered 
by either treatment, they suggest that the conversions of ALA and LA to long-chain 
PUFA may have been preferentially assimilated into brain tissue instead of the intestinal 
membranes. DHA supplementation has been shown in sheep to increase IgG content in 
colostrum (Keithly, 2010). Little literature exists on the effects of foal passive transfer 
when mares are supplemented with DHA during gestation and lactation. Stelzleni et al. 
(2006) reported no effects on immunoglobulin concentrations in mare colostrum or foal 
serum when pregnant and lactating mares received diets containing flaxseed, fish oil, or 
no supplementation. 
Mare Lactation and the Effects of PUFA Supplementation 
Compared to cow or human milk, mare milk is relatively low in fat. Initial 
secretion of colostrum only contains 0.7% fat and only increases to 1.8% fat during the 
first month of lactation (Lewis, 1995). Mare milk fat content then continues to slowly 
decrease after the first month of lactation. According to Lewis (1995), if a mare is 
adequately fed, her milk will provide the required nutrients needed by the foal for up to 2 
months. Mare milk has an abundant amount of short and medium chain fatty acids and 





FA and LA and ALA making up 5 to 20% and 12%, respectively (Doreau and Martuzzi, 
2006). Longer chain derivatives of LA and ALA, such as EPA and DHA have been found 
in very small quantities (less than 0.05 % of total FA) in mare milk (Gettinger, 2010). 
Dietary consumption of ALA can affect the concentration of ALA in mare milk. For 
example, consumption of a diet rich in fresh grasses has been shown to increase the 
proportion of ALA in milk fat to 15 to 25% of total FA as compared to 10% of total FA 
when fed a winter diet devoid of fresh grasses (Doreau and Martuzzi, 2006). LA levels 
can also be altered as Zeyner et al. (1996) found higher concentrations of LA in milk 
when supplementing lactating mares with soybean oil. These results seem to suggest that 
the FA concentration of mare milk could be influenced by n-3 supplementation, 
particularly DHA. 
Ideal Amount of DHA Supplementation During Mare Gestation 
While the ideal amount of DHA supplementation for the equine diet is still under 
investigation, human supplementation rates of 1.62 g DHA per day have shown a 
significant increase in DHA fatty acid profiles (Conquer and Holub, 1996). So far, equine 
nutritionists have adapted this effective level and compensated for a horse’s much larger 
size. In 2007, Woodward et al. fed horses 5.95 g of long chain n-3 PUFA containing 1.41 
g of EPA and 3.18 g of DHA daily and observed a significant increase in plasma DHA. 
In 2013, Adkin was able to supplement mares with only 2 g/d of DHA and still observed 
an increased concentration of DHA in mare plasma, umbilical cord plasma, foal plasma, 
mare RBC and mare milk (Adkin, 2013). However, research has indicated that levels are 
quickly discontinued after supplementation is ceased (King, 2007).
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CHAPTER IV 
MATERIALS AND METHODS 
Prior to the start of this study, the Sam Houston State University Institutional 
Animal Care and Use Committee approved all procedures involving animals. 
Animals 
Study 1 
Thirteen pregnant American Quarter Horse mares and their resultant foals were 
used for this study. Mares were sourced from local breeders. Mares ranged in age from 5-
22 yr and were at 310 days of gestation when treatments commenced. 
Study 2 
 Surplus blood and milk samples from American Quarter Horse mares and foals 
were obtained from local equine breeding farms in order to investigate normal ranges of 
plasma lipid concentrations in broodmares receiving industry standard diets. These 
samples were obtained from routine postpartum care protocols. These mares were housed 
in various locations as well as were on varying diets according to their management. 
Study Design 
Study 1 
 Mares were assigned to 1 of 3 treatments: unsupplemented control (CON; n=5), 
flaxseed (FLAX; n=3), or algae (ALG; n=5). The number of horses per treatment was 
determined based on a power analysis using data from previous research investigating 
plasma DHA concentrations in horses fed an algae-based supplement. Two horses are 
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missing from the FLAX treatment due to the COVID-19 pandemic, which shut down 
research operations prior to trial completion. 
Mares arrived at SHSU approximately 2-5 days prior to beginning treatments. 
Mares began supplementation 30 days prior to their expected foaling date (EFD) and 
continued for 5 days after parturition. Expected foaling dates ranged from January to 
June. For this reason, mares were sequentially assigned to treatments in order to 
minimize the effect of season, day length, and temperature.  
The study began Mid-January 2019 (n = 11; 4 CON, 4 ALG, 3 FLAX) and ended 
late March 2020 (n=2; 1 CON, 1 ALG). All mares were housed at the Sam Houston State 
University Agriculture Center (Latitude: 30.705592, -95.544408) for the duration of 
supplementation and through 5 d post foaling. All mares were housed individually in 
foaling stalls (3.66 m x 7.32 m) and allowed 1 hour of turnout time in a covered arena, 
daily. Five days after parturition, mares and foals were returned to their respective 
owners and supplementation ended. Routine vaccinations, deworming, and farrier 
schedules were maintained throughout the study. 
Study 2 
Mares and their resulting foals remained at their place of ownership and remained 
on normal diets and management practices. Many of the mares consumed diets including 
alfalfa hay and a pelleted ration designed for mares and foals which contained higher than 
14% crude protein. Blood and milk samples were obtained from these mares and their 
resulting foals within 10-14 h postpartum, per normal husbandry procedures evaluating 
foal health and colostrum quality. 
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Treatments and Diets for Study 1 
The basal ration for all 3 treatment groups included Coastal Bermudagrass hay, 
fed at 2% of BW, daily (Table 1). A grain-based concentrate (Calf Creep 14%, 
Producer’s Cooperative, Bryan, TX; Table 1) was fed at 0.6% BW, daily. Hay and 
concentrate were split into two equal meals, fed at 0600 h and 1800 h. Fresh water was 
available ad libitum. The diet was formulated in accordance with the National Research 
Council’s recommendations for mares that are pregnant or lactating (NRC, 2007). Foals 
also had access to their dam’s concentrate and supplement during twice daily feedings. 
Mares receiving a treatment had their supplement top dressed onto their individual basal 
ration. The ALG treatment consisted of an algal source of DHA (Probiotech, Saint-
Hyacinthe (Quebec) Canada; ALG), while FLAX consisted of a flax-based supplement 
(Smart & Simple Flax, SmartPak, Plymouth, Massachusetts; FLAX). Supplementation of 
mares began 30 d before EFD (d 310 gestation) and continued until d 5 post-partum 
(Table 1). The ALG and FLAX supplements were fed at a rate of 242.4 g and 190 g per 
day, respectively (120 mg/kg BW (As-fed basis)), which resulted in 40 g of DHA + EPA 
provided to the ALG treatment and 40 g of ALA provided to the FLAX treatment, daily. 
Supplements were hand-mixed into the grain concentrate immediately prior to feeding. 
Supplements were stored at 4° C until weighed and fed. The nutrient compositions of the 
grain-based concentrate, ALG and FLAX supplements, and Coastal Bermudagrass hay 




   
 
Table 1. Nutrient composition of three diets designed to differ in fatty acid content fed to 
late gestation mares for a minimum of 30 days. 
     Treatment Supplement 
Nutrient (DM basis) Hay Pellets ALG FLAX 
DE, MCal/kg 0.82 1.43 2.85 2.16 
Crude protein 9.5 22.8 0.5 24.1 
ADF 39.1 11.0 20.6 17.1 
NDF 72.2 25.2 36.8 24.2 
Fat 2.0 3.0 72.1 32.3 
Ash 7.35 6.54 7.73 4.12 
FA as % of Total FA     
C16:0 27.79 21.23 1.62 0.52 
C16:1 19.36 14.03 22.48 5.34 
C18:0 0 0 1.13 0 
C18:1 10.32 18.22 0 0 
C18:2 n6 7.66 8.56 38.19 29.06 
C18:3 n3 11.90 2.92 0 11.22 
C20:0 0 4.39 2.35 52.61 
C20:4 n6 0 1.03 1.55 0.08 
C20:5 n3 (EPA) 0 0 0 0.05 





   
 
Sample and Data Collection 
Blood and Milk Collection 
All blood samples were collected from the jugular vein, into syringes. Blood was 
then transferred into heparinized, evacuated tubes (Vacutainer, BD). Blood samples were 
collected from pregnant mares on the day prior to beginning supplementation, and at 1, 5, 
and 30 d post parturition. Blood was collected from the foal immediately following 
parturition and prior to suckling, 12 h post parturition, and 5 and 30 days post parturition 
(Figure 1). Following blood collection, samples were centrifuged for 10 min at 1500 × g 
and 4°C, after which plasma was harvested and frozen at −80 °C until analysis. 
A blood sample was also collected from each foal at 12 h post parturition for 
Serum IgG concentration. Samples were placed in uncoated, evacuated tubes 
(Vacutainer, BD) and allowed to clot at room temperature for 2 h. Serum was harvested 
and stored in the same manner as plasma.  
Between 20 and 30 mL of milk was manually collected into 50 mL collection 
tubes from both teats of the mare at 12 hr postpartum, 5 days after parturition and 30 days 
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Figure 1. Timeline of sample collection for the investigation of the effects of long-chain 
fatty acid supplementation of late gestation mares and their resulting foals.  
Body Condition Scores and Percent Body Fat 
Body Condition Scores (BCS) were subjectively appraised by the same researcher 
prior to starting supplementation, 12 h postpartum and 5 days postpartum. Scores were 
assigned using the 9-point scale described by Henneke et al. (1983), ranging from BCS 1 
(very poor) to BCS 9 (extremely fat).  
Rump fat thickness of mares was measured using B-mode ultrasonography prior 
to starting supplementation, and at 12 h 5 d post parturition. Measurements were taken 
from the rump at 5 cm lateral from the midline at the midpoint of the pelvic bone 
(Westervelt et al. 1976). The region was scanned and the position of maximal fat 
thickness was used as the measured site. Percent fat was estimated from the equations of 
Westervelt et al. (1976), where: % fat = 8.64 + (4.70 x cm rump fat).   
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Foal Measurements and Time to Stand and Nurse 
Measurements of each foal were taken at 12 h and 5 d postpartum. Measurements 
included weight, heart girth circumference, wither height, hip height, body length and 
cannon circumference.   
Time to stand was measured by starting a timer when parturition was complete 
and stopping time when the foal stood for a continuous 10 s. Time to nurse was measured 
by starting at the time that parturition was complete and ending when the foal had 
successfully latched onto the mare’s teat and was able to suckle.  
Sample Analysis  
Lipids were extracted from 3 mL plasma, dried and ground feed samples, milk fat 
cakes (following centrifugation) using 3:2 hexane-isopropanol as described by Corl et al. 
(2002).   
Milk Fat Extraction 
Lipids were extracted from milk fat cakes using 3:2 hexane-isopropanol (HIP) as 
described by Corl et al. (Corl et al., 2002). Mare milk samples were thawed at room 
temperature and then weighed into centrifuge tubes to 40 g total weight. Samples were 
centrifuged at 5,300 x g for 30 min at 8° C. Fat cakes were then weighed out and 300-350 
mg placed in a 16x150 screw top test tube. Eighteen mL hexane-isopropanol was added 
per g of fat cake and then vortexed for 30 s. Twelve mL of sodium sulfate solution per g 
of fat cake was then added and once again vortexed for 60 s. Samples were then 
centrifuged at 1000 x g for 5 min. The upper phase was transferred using a Pasteur 
pipette to a test tube containing 1 g of Na2SO4 and then purged with nitrogen. After 30 
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min of rest, the solvent was transferred to a fresh 16x100 screw top test tube and loaded 
onto an N-Evap with dry bath at 40° C. The solvent was then evaporated under a stream 
of nitrogen. Forty milligrams of the lipid was weighed out into a 16x100 screw top test 
tube and purged with nitrogen and stored at -20° C until methylation.  
Milk Fat Methylation 
Previously stored samples were warmed to room temperature and 2 mL of hexane 
and 40 µL of methyl acetate was added. Samples were then vortexed for 30 s and 40 µL 
of methylation reagent (0.4 mL sodium methoxide and 1.75 mL methanol) was added and 
then vortexed again for 2 min. After 8 minutes of rest, 60 µL of termination reagent (1 g 
oxalic acid dissolved in 30 mL diethyl ether) was added and then vortexed for 30 s. A 
small scoop of calcium chloride was added to the vial and the vial rested for 1 h. Samples 
were centrifuged at 2000 x g for 5 min and then the upper phase was transferred to a GC 
vial (Chouinard and Corneau, 1997). 
Plasma Fat Extraction and Methylation 
Plasma samples were thawed at room temperature and 3 mL of HIP was added to 
2 mL of plasma. Two milliliters of sodium sulphate was added, vortexed, and the upper 
phase removed. The sample was dried over 1 g of anhydrous sodium sulfate and the 
solution transferred to a fresh tube and dried under a stream of nitrogen. To this tube, 500 
µL of hexane was added as well as 40 µL of methyl acetate. The sample was then 
vortexed and 40 µL of methylation reagent (0.4 mL sodium methoxide and 1.75 mL 
methanol) added and then vortexed again. The samples were allowed to react at room 
temperature for 24 h and then 60 µL of termination reagent (1 g oxalic acid dissolved in 
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30 mL diethyl ether) was added. A few grains of calcium chloride was added to remove 
the water and the upper phase was removed for analysis (Perfield et al., 2006). 
Feed Lipid Extraction and Methylation 
Hay, grain and supplement samples were weighed out to 300 mg and placed into 16x150 
screw top test tubes. Then 5.4 mL of HIP was added to each sample and vortexed for 30 
s. Fat was then homogenized in HIP in a 12x75 snap cap tube and the homogenate 
transferred to glass test tube. Three mL of sodium sulphate solution was then added to 
each sample and vortexed for 30 s twice. Samples were then centrifuged at 1000 x g for 5 
min and the upper phase transferred using a Pasteur pipette to a test tube containing 0.5 g 
Na2SO4. Samples were purged with N2 and let stand for 30 min. The solvent was then 
transferred to a fresh 16x100 screw top test tube and loaded onto N-Evap with water bath 
at 40°C.  The solvent was then evaporated under a stream of N2. One mL of toluene and 2 
mL methanolic-sulfuric acid were added to the tube containing the extracted lipids and 
incubated in the heat block overnight at 50°C. One mL of 5% NaCl solution was added to 
the samples and extracted twice with 2 mL hexane transferring extracts to another test 
tube. Then 0.8 mL of 2% KHCO3 was added to the extracts and the upper hexane phase 
removed to a test tube containing 0.5 g Na2SO4, and let stand for 30 min. The solvent was 
then transferred to a new test tube and evaporated under nitrogen. Using 1 mL hexane, 
the sides of the test tube were washed and the solvent evaporated under nitrogen. 
Finally,100 µL of hexane were added to the dried extracts and transferred to a GC vial 




   
 
Fatty acid methyl esters from all samples were analyzed by gas chromatography 
(Agilent GC system 6890N with flame ionization detector using a DB-FastFame 20 m x 
0.18 mm i.d. column with 0.2 μm film thickness (Agilent Technologies)) to determine 
fatty acid composition. Injection port and detector temperatures were 275°C with a flow 
rate of 0.64 mL/min and was splitless. Initial oven temperature was 150°C and held for 1 
min and then there was an increase at 4°C/min to 210°C.  Peaks corresponding to specific 
fatty acids were identified using specific markers (Pure Methyl Ester Standards 68D and 
91, Nu-Check Prep Inc.). Although chromatographic analysis will result in the isolation 
and quantification of numerous FA, data will be analyzed and results reported for the 
following FA of particular interest: LA, ARA, ALA, EPA, and DHA. 
Serum IgG Analysis 
Foal serum samples were analyzed for IgG content using a commercially 
available ELISA test kit (IMMUNO-TEK, ZeptoMetrix, Buffalo, NY). Serum samples 
were diluted to 1:200,000 in assay diluent for initial testing. 200 µl of standards and 200 
µl of samples were pipetted into duplicate wells, covered and then incubated for 30 min 
at 37° C. The contents of each well were aspirated and the wells washed 4 times with 300 
µl of plate wash buffer. Then the plated were blotted dry. 100 µl of provided antibody 
detector was added to each standard and sample well and then covered and incubated for 
30 min at 37° C. The plate was once again washed 4 times and then 100 µl of substrate 
was added to each well. The plate was incubated for 30 min at room temperature until a 
blue color developed in wells containing equine IgG. 100 µl of the stop solution was 
added to each well to obtain a color change of blue to yellow. Optical density of each 
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sample was measured at 450 nm and the IgG concentration calculated using values 
provided by test kit.  
Statistical Analysis 
All statistical analyses were performed using the MIXED procedure of SAS 
(v.9.4, SAS Inst., Inc., Cary, NC). Fatty acid analysis used repeated measures ANOVA 
for the effects of time and treatment and the time by treatment interaction. Simple effect 
differences for time were detected by a Dunnett test which compares all time points back 
to time 0, and simple effect differences for treatment and the time by treatment 
interaction were determined using Tukey tests, which makes all possible comparisons. 
The autoregressive covariance structure for repeated analyses was the lowest AICC. The 
repeated term was day of study within horse. Growth measurements were evaluated for 









All mares completed the study and readily consumed the Algae (ALG), Flax (FLAX) and 
Control (CON) diets with no feed refusals (Table 2). 
Table 2. Daily average nutritional intake of mares supplemented with either 190 g of flax 
(FLAX) or 242.4 g of marine algae (ALG) daily for 30 days prior to expected parturition 
or in unsupplemented controls (CON). 
Nutrient Nutrient Intake 
 CON ALG FLAX 
Digestible Energy, Mcal 30.2 28.6 28.7 
Crude Protein, kg 1.80 1.71 1.73 
Acid Detergent Fiber, kg 4.64 4.40 4.38 
Neutral Detergent Fiber, kg 8.74 8.27 8.24 
Ether Extract, g 318.4 470.0 360.0 
18:2 n6, g 25.3 90.2 41.6 
18:3 n3, g 29.0 27.1 34.0 
20:5 n3, g 0 0 0.03 
22:6 n3, g 4.5 17.4 4.5 
 
Mare and Foal Bodyweight 
No treatment differences existed for BW among mares throughout the study (P > 0.4; 
Table 3). Average BW at study commencement (d 310 of gestation) for ALG mares was 
518.0 ± 11.4 kg, 518.5 ± 14.7 kg for FLAX mares and 550.7 ± 11.4 kg for CON mares. 
The average BW at study completion (d 5 postpartum) for ALG mares was 492.60 ± 11.4 
kg, FLAX 491.69 ± 14.7 kg and CON 501.21 ± 11.4 kg. Bodyweight was affected by day 
(P <0.001), but not the time x treatment (P= 0.33) interaction, whereby average BW on 
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day -30 (529.51 ± 8.9 kg) was greater than on day 0 (499.76 ± 8.9 kg; P <0.001), and 5 
(495.44 ± 8.9 kg; P= 0.001). 
Table 3. Bodyweights of mares supplemented with either 190 g of flax (FLAX) or 242.4 
g of marine algae (ALG) daily for 30 days prior to expected parturition and bodyweights 
of unsupplemented controls (CON). 
Treatment 
(TRT) 
Bodyweight (kg)  P-Value 
 Day -30a Day 0b Day 5b SEM TRT Time TRT x 
Time 
CON 550.66  501.67 501.21 11.38    
ALG 518  498.95 492.60 11.38 0.48 <0.001 0.33 
FLAX 518.45  493.96 491.69 14.65    
 
Average foal weights were affected by treatment (P= 0.03) but not the time by treatment 
interaction (P = 0.6; Table 4). Foals born to CON mares weighed more on average (49.9 
± 2.8 kg) than foals born to FLAX mares (39.3 ± 2.8 kg; P = 0.03), but not foals born to 
ALG mares (44.5 ± 2.13 kg; P > 0.2). Foal BW was affected by time (P < 0.001); 
whereby foals were heavier on day 5 (47.9 ± 1.4) than day 0 (41.2 ± 1.4; P < 0.001).  
Table 4. Bodyweights (kg) of foals born to mares supplemented with either 190 g of flax 
(FLAX) or 242.4 g of marine algae (ALG) daily for 30 days prior to expected parturition 
and bodyweight of foals from unsupplemented controls (CON).  
Treatment 
(TRT) 
Bodyweight (kg)  P-Value 
 Day 0 Day 5 SEM TRT 
Mean 
TRT Time TRT x 
Time 
CON 46.87 53.16 2.23 49.9a    
ALG 41.45 47.53 2.23 44.5b 0.03 <0.001 0.64 
FLAX 35.38 43.24 2.88 39.3c    
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Mare Body Fat Percentage and Body Condition Score 
Mare body fat percentage was affected by time (P < 0.001) whereby body fat was greater 
on d 0 (11.48 ± 0.24 %; P < 0.001) and 5 (11.54 ± 0.24 %; P < 0.001) than d -30 (10.2 ± 
0.24 %)(Table 5). No differences in percent body fat were observed between treatments 
(P > 0.9) or the treatment by time interaction (P > 0.6). Body condition scores were not 
affected by time, treatment, or the time by treatment interaction (P > 0.08). 
Table 5. Body fat percentage and body condition score (BCS) of mares supplemented 
with either 190 g of flax (FLAX) or 242.4 g of marine algae (ALG) daily for 30 days 
prior to expected parturition or in unsupplemented controls (CON).  
Treatment 
(TRT) 
Morphometric Measurement P-Value 
 Day -30 Day 0 Day 5 SEM TRT Time TRT X 
Time 
 --Body Fat, %--     






ALG 10.50 11.36 11.40 0.37    
FLAX 9.97 11.67 11.75 0.49    
 --Body Condition Score, unit--     
CON 6.7 6.1 5.9 0.37    
ALG 5.7 5.6 5.6 0.37 0.41 0.08 0.52 
FLAX 5.8 5.5 5.6 0.60    
 
Foal Time to Stand, Time to Nurse and Gestation Length 
No treatment difference in time to stand was observed among foals (P > 0.8; Table 6). 
Average time to stand was 32.6 ± 12.09 min for foals born to ALG mares, 42.33 ± 15.61 
min for foals born to FLAX mares and 36.40 ± 12.09 min for foals born to CON mares.  
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Table 6. Time to stand (min) in foals born to mares supplemented with either 190 g of 
flax (FLAX) or 242.4 g of marine algae (ALG) daily for 30 days prior to expected 
parturition or in unsupplemented controls (CON).  
Treatment Time to Stand SEM P-Value 
CON 36.40 12.09  
0.88 
ALG 32.60 12.09  
FLAX 42.33 15.61  
 
No treatment difference in time to nurse was observed among foals (P > 0.2; Table 7). 
Average time to nurse was 61.80 ± 13.24 min for foals born to ALG mares, 98.33 ± 17.10 
min for foals born to FLAX mares and 83.80 ± 13.24 min for foals born to CON mares.  
Table 7. Time to nurse in foals born to mares supplemented with either 190 g of flax 
(FLAX) or 242.4 g of marine algae (ALG) daily for 30 days prior to expected parturition 
or in unsupplemented controls (CON). 
Treatment Time to Nurse SEM P-Value 
CON 83.80 13.24  
0.25 
ALG 61.80 13.24  
FLAX 98.33 17.10  
 
No treatment difference in length of gestation was observed among mares (P > 0.4; Table 
8) Average length of gestation was 337.20 ± 2.79 days for ALG mares, 331 ± 3.61 days 
for FLAX mares and 333.8 ± 2.79 days for CON mares.  
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Table 8. Gestation length of mares (days) supplemented with either 190 g of flax 
(FLAX) or 242.4 g of marine algae (ALG) daily for 30 days prior to expected parturition 
or in unsupplemented controls (CON). 
Treatment Length of gestation, 
days 
SEM P-value 
CON 333.80 2.79  
0.41 
ALG 337.20 2.79  
FLAX 331.00 3.61  
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Foal Plasma Fatty Acids 
Analysis of samples identified numerous fatty acids within the samples. This study 
focused primarily on the following fatty acids: 14:0, 14:1, 16:0, 16:1, 18:0, 18:1, 18:2, 




   
 
Table 9. Fatty acid content of plasma as a percentage of total fatty acids from foals born 
to mares supplemented with either 190 g of flax (FLAX) or 242.4 g of marine algae 




Plasma Fatty Acid, % P-Value 
 Day 0 Day 5 Day 30 SEM TRT Time TRT X 
Time 
 --14:0--    0.03 <0.001 0.25 
Day Mean 0.31 2.86** 2.56** 0.21    
CONa 0.12 2.70 1.73 0.37    
ALGb 0.26 2.99 3.30 0.33    
FLAXab 0.55 2.89 2.63 0.42    
 --16:0--    0.97 0.01 0.33 
Day Mean 27.39 22.92* 19.21** 1.85    
CON 30.80 22.04 15.57 3.00    
ALG 26.13 22.96 21.37 2.84    
FLAX 25.26 23.76 20.69 3.67    
 --16:1--    0.44 0.003 0.15 
Day Mean 2.25 1.30** 1.52 1.26    
CON 5.05 3.19 3.57 1.99    
ALG 1.24 0.65 0.59 1.98    
FLAX 0.48 0.07 0.40 2.56    
 --18:0--    0.82 0.14 0.45 
Day Mean 12.39 8.56 9.98 2.29    
CON 10.75 7.61 10.58 3.75    
ALG 13.01 12.43 10.48 3.53    
FLAX 13.42 5.64 8.88 4.56    
 --18:1--    0.36 0.002 0.36 
Day Mean 23.37 11.20** 8.69** 2.78    
CON 20.84 16.73 15.72 4.70    
ALG 25.70 7.11 3.57 4.21    
FLAX 23.57 9.77 6.80 5.44    





   
 
Table 9. Fatty acid content of plasma as a percentage of total fatty acids from foals born 
to mares supplemented with either 190 g of flax (FLAX) or 242.4 g of marine algae 




Plasma Fatty Acid, % P-Value 
 Day 0 Day 5 Day 30 SEM TRT Time TRT X 
Time 
 --18:2 n6--    0.64 <0.001 0.37 
Day Mean 23.09 39.48** 45.99*** 4.03    
CON 21.38 40.58 48.45 6.71    
ALG 20.74 45.09 53.12 6.16    
FLAX 27.14 32.78 36.40 7.95    
 --18:3 n3--    0.15 0.006 0.09 
Day Mean 0.37 6.77** 7.94** 2.22    
CON 0.40 1.76 2.57 3.55    
ALG 0.17 3.24 4.19 3.41    
FLAX 0.17 1.03 1.01 0.16    
 --20:4 n6--    0.19 0.06 0.06 
Day Mean 0 0.11* 0.02 0.03    
CON 0 0 0.03 0.05    
ALG 0 0.04 0.05 0.05    
FLAX 0 0.30 0 0.06    
 --20:5 n3--    0.06 0.13 0.06 
Day Mean 0.16 0.21 0.005 0.08    
CON 0 0.01 0.01 0.13    
ALG 0.32 0.63 0 0.12    
FLAX 0.18 0 0 0.16    
 --22:6 n3--    0.03 <0.001 0.06 
Day Mean 1.15 0.31*** 0.02*** 0.12    
CONa 0.55 0.19 0.007 0.21    
ALGb 1.90 0.56 0.08 0.21    
FLAXab 1.11 0.23 0 0.25    
41 
 
   
 
For 14:0, there was no effect of the day by treatment interaction, however there was an 
effect of treatment (P = 0.03) whereby ALG foals (2.18 ± 0.15 %) had greater 14:0 
plasma concentrations than CON (1.52 ± 0.17 %; P = 0.03). There was also an effect of 
day (P < 0.001) whereby the percent of 14:0 in plasma was lower on day 0 (0.31 ± 0.21 
%) than days 5 (2.86 ± 0.21 %; P < 0.001) and 30 (2.56 ± 0.21 %; P < 0.001). For 16:0, 
there was an effect of day (P = 0.01) whereby the percent of 16:0 in plasma was higher 
on day 0 (27.39 ± 1.87 %) than days 5 (22.92 ± 1.86 %; P = 0.07) and 30 (19.21 ± 1.81 
%; P = 0.007). For 16:1, there was an effect of day (P = 0.003) whereby the percent of 
16:1 in plasma was higher on day 0 (2.25 ± 1.27 %) than day 5 (1.30 ± 1.26 %; P = 
0.002), but not day 30. There was also a tendency for an effect on day whereby the 
percent of 16:1 in plasma was lower on day 5 (1.30 ± 1.26 %) than day 30 (1.52 ± 1.26 
%; P = 0.08). For 18:0 there was no effect of treatment, time, or treatment x time 
interaction. For 18:1, there was an effect of day (P = 0.002) whereby the percentage of 
18:1 in plasma was higher on day 0 (23.37 ± 2.78 %) than day 5 (11.20 ± 2.78 %; P = 
0.006 ) and higher on day 5 (11.20 ± 2.78 %) than day 30 (8.69 ± 2.69 %; P = 0.002). For 
18:2 n-6, there was an effect of day (P < 0.001) whereby the percentage of 18:2 in plasma 
was lower on day 0 (23.09 ± 4.05 %) than day 5 (39.48 ± 4.03 %; P = 0.001) and lower 
on day 5 (39.48 ± 4.03 %) than day 30 (45.99 ± 3.93 %; P < 0.001). For 18: 3 n-3, there 
was an effect of day (P = 0.006) whereby the percent of 18: 3 in plasma was lower on day 
0 (0.37 ± 2.24 %) than day 5 (6.77 ± 2.22 %; P= 0.005) and lower on day 5 than day 30 
(7.94 ± 2.18 %; P = 0.009). For 20:4 n-6, there was a tendency for the effect of treatment 
by day interaction (P = 0.06) whereby the percentage of 20:4 in plasma was greater in 
foals born to FLAX mares on day 5 than all other samples (0.30 ± 0.06 %, P < 0.05). For 
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EPA (20:5 n-3), there was a tendency for effect of treatment by day interaction (P = 0.06) 
whereby foals born to ALG mares on day 5 (0.63 ± 0.12 %) had greater levels than foals 
born to CON mares on day 0 (P = 0.06), day 5 (P = 0.08), and day 30 (P = 0.05). For 
docosahexaenoic acid (DHA, 22:6 n-3), there was an effect of treatment (P = 0.04) 
whereby the percentage of 22:6 in plasma was higher in foals born to ALG mares (0.79 ± 
0.11 %) than foals born to CON mares (0.55 ± 0.21 %; P= 0.02) but was not different 
from that of foals born to FLAX mares (1.11 ± 0.25 %; P= 0.22). There was also an 
effect of day (P < 0.001) whereby the percentage of 22:6 in plasma was greater on day 0 
(1.15 ± 0.12 %) than days 5 (0.31 ± 0.12 %; P = 0.001) and 30 (0.02 ± 0.11 units; P < 
0.001). There was also a tendency for effect of treatment by day interaction (P = 0.06) 
whereby the percentage of 22:6 in plasma was greater for foals born to ALG mares on 
day 0 (1.90 ± 0.18 %) than in the same foals on days 5 (P = 0.001) and 30 (P = 0.001), 
and in foals born to CON mares on days 0 (P = 0.007), 5 (P < 0.001), 30 (P < 0.001) and 
foals born to FLAX mares on days 5 (P = 0.002) and 30 (P < 0.001). 
Mare Plasma Fatty Acids 
Analysis of the mare plasma for FA resulted in no significant differences observed apart 










   
 
Table 10. Fatty acid content of plasma as a percentage of total fatty acids from mares 
supplemented with either 190 g of flax (FLAX) or 242.4 g of marine algae (ALG) daily 
for 30 days prior to parturition or in unsupplemented controls (CON).  
Treatment 
(TRT) 
Plasma Fatty Acid, % P-Value 
 Day -30 Day 0 Day 5 Day 30 SEM TRT Time TRT X 
Time 
 --14:0--        
Day Mean 0.90 0.67 0.05 0.27 0.42 0.43 0.32 0.61 
CON 2.07 0.93 0.05 0.76 0.58    
ALG 0.24 0.52 0.08 0.02 0.58    
FLAX 0.41 0.57 0.04 0.02 0.76    
 --16:0--     0.09 <0.001 0.41 
Day Mean 17.07 21.14*
* 
19.53 18.41 1.29    
CON 15.93 18.14 15.45 14.58 1.91    
ALG 16.54 20.21 18.92 19.15 1.91    
FLAX 18.76 25.08 24.23 21.50 2.47    
 --16:1--     0.50 0.75 0.62 
Day Mean 0.97 1.07 1.32 1.41 1.43    
CON 2.87 2.95 3.88 4.23 2.25    
ALG 0.05 0.09 0.07 0 2.25    
FLAX 0 0.16 0 0 2.90    
 --18:0--     0.51 0.27 0.78 
Day Mean 17.65 13.52 16.08 15.46 2.25    
CON 17.33 8.94 13.79 15.16 3.53    
ALG 20.96 16.44 18.18 16.74 3.53    
FLAX 14.68 15.18 16.27 14.47 4.56    
 --18:1--     0.33 0.24 0.86 
   Day Mean 4.58 6.20 4.95 5.03 1.91    
CON 6.81 9.80 9.34 9.70 2.99    
ALG 4.73 4.86 3.58 3.49 2.99    
FLAX 2.19 3.94 1.93 1.92 3.87    
(Continued)         
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 Table 10. Fatty acid content of plasma as a percentage of total fatty acids from mares 
supplemented with either 190 g of flax (FLAX) or 242.4 g of marine algae (ALG) daily 
for 30 days prior to parturition or in unsupplemented controls (CON). 
Treatment 
(TRT) 
Plasma Fatty Acid, % P-Value 
 Day -30 Day 0 Day 5 Day 30 SEM TRT Time TRT X 
Time 
 --18:2 n6--     0.54 0.82 0.19 
 Day Mean 51.75 53.58 54.22 54.43 3.09    
CON 43.28 53.49 51.97 49.23 4.84    
ALG 53.07 54.44 55.17 57.07 4.84    
FLAX 58.90 52.83 55.53 56.98 6.25    
 --18:3 n3--     0.46 0.54 0.80 
 Day Mean 2.85 1.96 1.03 1.67 0.89    
CON 5.17 2.82 0.67 2.39 1.39    
ALG 1.66 1.21 0.77 1.75 1.39    
FLAX 1.73 1.86 1.64 0.87 1.80    
 --20:2 n6--     0.03 0.07 0.40 
 Day Mean 0.16 0.42 0.29 0.58 0.12    
CONa 0.07 0.42 0.08 0.23 0.20    
ALGa 0.11 0.12 0.18 0.23 0.20    
FLAXb 0.31 0.72 0.62 1.27 0.26    
 --22:6 n3--     0.22 0.57 0.26 
 Day Mean 0.44 0.10 0.54 0.93 0.41    
CON 1.33 0.26 1.45 0.27 0.65    
ALG 0 0.04 0.17 0 0.65    
FLAX 0 0 0 2.53 0.84    
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There was an effect of day for 16:0 (P < 0.001) whereby plasma percentages of 16:0 were 
highest on day 0 (21.14 ± 1.29, P < 0.001) when compared to day -30 (17.07 ± 1.29 %). 
There was an effect of treatment for 20:2 (P = 0.03) whereby plasma percentages of 20:2 
for FLAX supplemented mares (0.73 ± 0.16 %) were greater than those of ALG 
supplemented mares (0.16 ± 0.12 %; P = 0.03) and CON mares (0.20 ± 0.12 %; P = 
0.05). 
Mare Milk Fatty Acids 
Mare milk yielded no observed differences for the effects of treatment (P > 0.3; Table 
11), with the exception of 20:2 which had a treatment effect (P = 0.008) whereby ALG 
treated mares (0.39 ± 0.1) had lower concentrations of 20:2 in their milk than FLAX 
treated mares (1.36 ± 0.2; P < 0.01) but not CON mares (0.6 ± 0.2; P = 0.7). There was 
also an effect of day for 20:2 (P = 0.01) where concentrations on day 5 (1.08 ± 0.2) were 





   
 
Table 11. Fatty acid content of milk as a percentage of total fatty acids from mares 
supplemented with either 190 g of flax (FLAX) or 242.4 g of marine algae (ALG) daily 
for 30 days prior to expected parturition or in unsupplemented controls (CON).  
Fatty Acid Day postpartum  P-Value 
 D 0 SEM D 5 SEM TRT Time TRT X Time 
14:0     0.73 0.49 0.27 
CON 5.79 1.58 7.12 3.16    
ALG 6.67 1.41 5.21  1.57    
FLAX 5.53 1.82 9.46  2.21    
14:1     0.32 0.84 0.14 
CON 2.01 2.21 6.82 4.42    
ALG 7.25 1.97 0.45 2.21    
FLAX 0.31 2.55 0.06 3.12    
16:0     0.57 0.75 0.18 
CON 22.42 2.16 18.58  4.33    
ALG 20.63 1.93 23.17 2.04    
FLAX 25.35  2.50 23.01 2.77    
C16:1     0.48 
 
0.64 0.67 
CON 0.02 0.27 0 0.54    
ALG 0.21 0.24 0.05 0.27    
FLAX 0.77 0.31 0.11 0.38    
18:1     0.86 0.44 0.11 
CON 28.21 2.85 24.22  5.71    
ALG 21.74 2.55 27.12 2.70    
FLAX 30.88 3.30 18.09 3.67    
18:2     0.85 0.14 0.30 
CON 29.13 3.90 32.18 7.81    
ALG 25.63 3.49 30.83  3.88    
FLAX 20.02 4.50 39.58  5.46    
18:3     0.23 0.19 0.31 
CON 4.06 2.18 12.77  4.36    
ALG 3.77 1.95 3.15  2.17    
FLAX 2.74 2.51 4.20 3.07    
20:0     0.55 
 
0.43 0.51 
CON 0.08 0.15 0  0.31    
ALG 0.06 0.14 0.40  0.15    
FLAX 0.28 0.18 0.28  0.22    
(Continued)        
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Table 11. Fatty acid content of milk as a percentage of total fatty acids from mares 
supplemented with either 190 g of flax (FLAX) or 242.4 g of marine algae (ALG) daily 
for 30 days prior to expected parturition or in unsupplemented controls (CON). 
Fatty Acid Day Postpartum P-Value 
 D 0 SEM D 5 SEM TRT Time TRT X 
Time 
20:2 a  b  0.008 0.01 0.19 
CONa 0.61 0.19 0.59  0.39    
ALGa 0.005 0.17 0.78  0.19    
FLAXb 0.85 0.22 1.88 0.27    
20:3     0.55 0.79 0.55 
CON 0 1.30 0 2.60    
ALG 2.83 1.16 0.02 1.30    
FLAX 0 1.50 0.05 1.84    
20:4     0.13 0.93 0.34 
CON 0 0.55 0 1.10    
ALG 0.74 0.49 0.44  0.51    
FLAX 0.25 0.63 1.45  0.69    
20:5     0.83 0.61 0.83 
CON 0.03 0.02 0 0.04    
ALG 0.01 0.01 0 0.02    
FLAX 0 0.02 0 0.02    
22:6     0.60 0.75 0.73 
CON 0.42 1.75 0  3.50    
ALG 3.67 1.56 0.51  1.75    
FLAX 0.64 2.02 0.07 2.47    
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Foal Serum IgG: 
No significant differences were observed between treatments for serum IgG 
concentrations of foals at 12 hours of life (Table 12). 
Table 12. Serum IgG concentrations at 12 hours of life of foals born to mares 
supplemented with either 190 g of flax (FLAX) or 242.4 g of marine algae (ALG) daily 
for 30 days prior to parturition or in unsupplemented controls (CON).  
Treatment Serum IgG, mg/dL SEM P-Value 
CON 1502 272  
0.572 
ALG 1158 304  
FLAX 1682 430  
 
Industry Foal Plasma and Mare Milk Analysis: 
Results of foal plasma and mare milk analysis from the accessory industry survey is 
located in Table 13. 
Table 13. Average fatty acid content as a percentage of total fatty acids of industry foal 
plasma and industry mare milk at 1 day of age.  
Fatty Acid Fatty Acid, % 
 Foal Plasma (n=20) Mare Milk (n=29) 
14:0 2.32 5.75 
14:1 0.14 1.83 
16:0 16.48 19.04 
16:1 0.25 0.02 
18:1 15.92 20.63 
18:2 54.96 25.97 
18:3 3.56 1.48 
20:2 0.74 1.90 
20:3 0.92 1.13 
20:4 0.34 0.02 
20:5 0.03 0.02 
22:6 0.18 0.59 
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The primary objectives of this study were to compare mare and foal plasma fatty acid 
compositions and mare milk fatty acid composition to determine whether late gestation 
dietary omega-3 fatty acid supplementation would increase the percentage of ALA, EPA, 
and DHA in plasma and milk. Further objectives were to determine whether the source of 
omega-3 fatty acids, either algae or flaxseed, would have beneficial effects on neonatal 
foal growth, time to stand, and time to nurse.  
The main finding of this study was that foals from supplemented mares benefitted from 
increased plasma DHA at birth, and further, that ALG foals had greater plasma EPA at 
birth. This study’s results are consistent with other recent studies indicating that the 
dietary supplementation of marine-derived omega-3 fatty acids to mares in late gestation 
and early lactation results in increased plasma DHA and EPA levels in their resulting 
foals (Hess et al., 2012; Adkin, 2013; Kouba et al., 2019). However, there was no 
difference in EPA and DHA concentrations at birth between foals born to ALG or FLAX 
treated mares, so it cannot be said that the algae was more effective than the flax 
supplement at increasing plasma DHA levels. The current study observed slightly 
different results than Moallhem and Zachut (2012), who observed almost twice the 
concentration of plasma DHA in newborn calves from dams supplemented with fish oil 
when compared to calves from flaxseed oil-supplemented or control diet cows. It is 
possible that our sample size was too low to detect differences. Original planning 
included sampling of additional experimental units, however these could not be obtained 
due to the COVID-19 pandemic. Alternatively, it is possible that fetal tissues effectively 
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elongate and desaturate precursor fatty acids. Stammers et al. (1991) observed that certain 
long chain polyunsaturated derivatives of the essential fatty acids found in the umbilical 
venous plasma phospholipid fraction were not seen in the maternal circulating lipids, but 
the precursor fatty acids were readily available to both fetal and placental tissues, 
suggesting they had been elongated and incorporated into phospholipids by fetal and 
placental tissues. 
Interestingly, the samples obtained prior to the foal suckling from the algae supplemented 
mares had the highest DHA content compared to all other samples. This is consistent 
with other studies that have also observed DHA levels being highest before nursing 
(Kouba et al., 2019). This provides encouraging evidence that this transfer of DHA from 
the mare to foal is made during gestation. Fetal transfer is observed in humans, with fetal 
erythrocytes playing a role in uptake of DHA and ARA from maternal blood (Ruyle et 
al., 1990). Further, DHA is preferentially transferred to fetal circulation in humans, with 
greater uptake than other omega 3 and 6 fatty acids (Haggarty et al., 1997). In mares, 
Stammers et al. (1991) observed a positive correlation between maternal and umbilical 
vein plasma free fatty acid concentrations which included substantial amounts of 
essential fatty acids and their longer chain derivatives, suggesting that the equine placenta 
is permeable to long chain fatty acids. This previous study paired with the current study’s 
observations support the hypothesis that there is placental EFA transfer to the equine 
fetus when mares are supplemented during late gestation. 
The pattern of DHA levels in neonatal foal plasma suggests that placental transfer may be 
a more efficient mechanism of DHA absorption than maternal milk supply. Long chain 
fatty acids represent a low percentage of mare’s milk, as indicated through both our day 0 
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milk samples and the samples obtained from industry mares. As milk is the sole 
component of a neonatal foal’s diet, placental transfer may be more efficient than milk 
consumption at providing foals with long chain EFA.  
While both supplements provided ALA (18: 3), FLAX mares consumed more. Despite 
this, there was no treatment effect on foal ALA percentages at birth. It is possible this is 
due to preferential transfer of longer chain fatty acids or elongation of ALA to EPA and 
DHA. These longer fatty acids, and particularly DHA, are necessary for the proper 
development of brain tissues, which are still developing at the time of birth, therefore 
production of DHA in utero is essential. Intriguingly, the pattern of ALA in neonatal 
plasma over time, opposes that of DHA, with a steady increase through the 30 day post 
parturition sample collection. Similarly, Kouba et al. (2019) observed that foal plasma 
ALA increased significantly after birth and stayed elevated through 21 days of life.  As 
time increases it is possible that less of the ALA is being converted into DHA allowing 
for more accumulation of the fatty acid in the foal plasma. It is also possible that foals 
began consuming more ALA, as they frequently begin consuming pasture, hay, and their 
dam’s feed. However, it is unlikely that any solid feed consumed will be well digested 
until several weeks of age when the large colon matures (McKenzie and Geor, 2007). 
Grass hay and pasture are good sources of ALA, but contain only low amounts of DHA. 
While not a target of treatment, we also observed changes in omega-6 fatty acid 
concentrations, mono-unsaturates, and saturated fatty acids. As for the omega-6 fatty 
acids, both 18:2 n6 and 20:4 n6 increased from birth, although for 20:4 n6, this finding 
may have been primarily driven by the high percentage in FLAX foals on day 5.  
Duvaux-Ponter et al. (2004), observed that 18:2 and 18: 3 levels in foal increased after 
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suckling, whereas in contrast levels of 20:3 and 20:4 were highest at birth and decreased 
after suckling. As observed from our industry mares and foals, 18:2 n6 is the most 
abundant fatty acid in foal plasma and mare milk. Similarly, Kouba et al. (2019) also 
observed that LA (18:2) was the most abundant fatty acid in foal plasma and mare milk 
across treatments and time. The reason for 18:2 having the highest concentrations could 
possibly be related to the fact that LA is the precursor to ARA (20:4) which is important 
for synthesizing a variety of hormones that are vital to several body processes. The high 
levels of 18:2 in the plasma would suggest that it is required to be readily available to the 
body in large amounts to optimize body development and function. Another possibility 
relates to 18:2 being the most abundant fatty acid in the diet provided to the mares 
resulting in more of the fatty acid being absorbed into the blood stream. The primary 
theme among the saturates and mono-unsaturates was a reduction from birth, excepting 
14:0, which increased in percent as time increased. 
While previous research has observed increased DHA levels in the plasma of mares 
supplemented with an algae supplement (Adkin, 2012), this study did not observe any 
differences in mare plasma fatty acid levels of ALG treatment mares compared to FLAX 
and CON mares. The reason for this inconsistency may be due to differences in 
experimental design or differing supplement composition. One other observation was that 
mare plasma EPA levels were mostly not detectable throughout the study, regardless of 
treatment. Adkin (2012) also reported this finding when supplementing mares with an 
algal supplement. In contrast, Kouba et al. (2019) observed that when mares were 
supplemented with DHA and EPA (10.43 g and 8.84 g daily, respectively) for 60 days 
prior to parturition, they expressed higher levels of EPA and DHA in both plasma and 
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milk. Further, the current study is also inconsistent with findings of non-pregnant animals 
that have been supplemented with marine-derived omega-3's. For example, King et al. 
(2008) observed significantly higher EPA and DHA plasma concentrations in mares fed 
681 g/day of a marine derived supplement designed to supply 10, 20 or 40 g/day of EPA 
and DHA depending on treatment. Similarly, Hess et al. (2012) observed elevated EPA 
and DHA concentrations in mares fed a marine algae supplement providing 2 g of ALA, 
7.6 g of EPA, 26.6 g of DHA and 1.7 g of docosapentaenoic acid (DPA) daily. That 
specific study did not observe any detectable levels of EPA or DHA in mares 
supplemented with a flax supplement.  
While previous research suggests the same trends observed in mare plasma to be 
observed in the milk FA analysis for various species (sows: Meers et. al, 2006; cows: 
Mattos et. al, 2004; women: Olafsdottir et. al, 2006), this study saw no significant 
differences in mare milk FA levels in regard to treatment or time. Results of treatment 
mare milk analysis were comparable to results of the industry mare milk analysis. The 
current study observed minimal levels of DHA in the mare milk and while the values 
suggest increased DHA in ALG treated mares, the numbers must be taken lightly due to 
the small sample size. Duvaux-Ponter et al. (2004), reported not observing any DHA in 
mare milk when supplementing with either rapeseed or linseed. More generally, Pikul 
and Wojtowski (2008) were not able to detect any EPA or DHA when sampling mare 
milk for fatty acid composition. Similarly, in humans, women supplemented with 
flaxseed oil did not have increased DHA levels in their breast milk (Francois et al., 2003). 
These reports support the theory suggesting there is limited capability for lactating mares 
to transfer DHA into milk. Paired with the results of the foal plasma, this suggests the 
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most effective avenue for supplying the foal with DHA is in utero through late gestation 
maternal supplementation. 
With regard to neonatal health, this study observed no differences in IgG concentration of 
foal plasma at 12 hours of life. This is consistent with Adkin’s (2012) findings that foal 
serum IgG content was not affected by treatment at 24-36 hours of life. While the current 
study did not investigate the IgG content of mare colostrum, other studies have shown 
that there was no difference in mare colostrum IgG content observed between mares fed 
marine derived algae and a basal corn diet (Kouba et. al, 2019). Previous studies had 
suggested that maternal supplementation of marine derived algae would result in longer 
gestation lengths as well as a shorter time to stand and suckle by offspring. However, this 
study did not observe any significant difference in treatments in any of these values for 
the foals. A previous study had investigated the effects of FA supplementation on rump 
fat thickness for mares in maintenance and had observed no differences between groups 
receiving corn oil and those on a control diet (Headley, et. al, 2012). The current study 








Dietary supplementation of mares with marine-derived algae during late gestation alters 
the FA composition of the foal plasma at birth, resulting in higher concentrations of EPA 
and DHA. Foals that are in utero and that are suckling their dams had a transfer of these 
PUFA into their blood. The findings of this study paired with the previous efforts of other 
researchers suggests that the most efficient avenue for increasing foal DHA is through 
maternal supplementation during gestation, and that supplementation during the final 30 
days is sufficient to see changes. Further research should investigate if beginning 
supplementation earlier in gestation would affect mare circulating fatty acid profiles as 
well as impact foal development. Furthermore, future research should investigate if 
continuance of supplementation to the mare through the lactation period and then to the 
foal in early adolescence would continue to affect foal DHA levels. While previous 
research has begun to investigate the beneficial effects of DHA for foals, consistent 
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